DE602006015421D1 - HER-2/neu Multipeptidimpfstoff - Google Patents

HER-2/neu Multipeptidimpfstoff

Info

Publication number
DE602006015421D1
DE602006015421D1 DE602006015421T DE602006015421T DE602006015421D1 DE 602006015421 D1 DE602006015421 D1 DE 602006015421D1 DE 602006015421 T DE602006015421 T DE 602006015421T DE 602006015421 T DE602006015421 T DE 602006015421T DE 602006015421 D1 DE602006015421 D1 DE 602006015421D1
Authority
DE
Germany
Prior art keywords
neu
vaccine
multipept
multiepitope
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006015421T
Other languages
English (en)
Inventor
Christoph Zielinski
Otto Schreiner
Hubert Pehamberger
Heimo Breiteneder
Ursula Wiedermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh
Original Assignee
Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh filed Critical Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh
Publication of DE602006015421D1 publication Critical patent/DE602006015421D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103—Receptors for growth factors
    • A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55533—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
DE602006015421T 2006-04-13 2006-04-13 HER-2/neu Multipeptidimpfstoff Active DE602006015421D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06007834A EP1844788B1 (de) 2006-04-13 2006-04-13 HER-2/neu Multipeptidimpfstoff

Publications (1)

Publication Number Publication Date
DE602006015421D1 true DE602006015421D1 (de) 2010-08-26

Family

ID=37110206

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006015421T Active DE602006015421D1 (de) 2006-04-13 2006-04-13 HER-2/neu Multipeptidimpfstoff

Country Status (9)

Country Link
US (1) US20090269364A1 (de)
EP (2) EP1844788B1 (de)
AT (1) ATE473758T1 (de)
AU (1) AU2007237491B2 (de)
CA (1) CA2649013C (de)
DE (1) DE602006015421D1 (de)
ES (1) ES2348312T3 (de)
IL (1) IL194162A (de)
WO (1) WO2007118660A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0724357D0 (en) * 2007-12-14 2008-01-23 Glaxosmithkline Biolog Sa Method for preparing protein conjugates
JP2010006705A (ja) * 2008-06-13 2010-01-14 Atlas Antibodies Ab Ｈｅｒ２サブセット
WO2010057197A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
SG177637A1 (en) * 2009-07-30 2012-03-29 Pfizer Vaccines Llc Antigenic tau peptides and uses thereof
EP2292258A1 (de) * 2009-08-18 2011-03-09 Pevion Biotech Ltd. Multiepitop-Impfstoff für Her2/neu-assoziierten Krebs
CN104066447A (zh) * 2011-11-23 2014-09-24 拜奥文斯瑞有限公司 重组蛋白及其治疗用途
CA2863658C (en) * 2012-02-03 2023-03-14 Emory University Immunostimulatory compositions, particles, and uses related thereto
AU2016250289B2 (en) 2015-04-17 2017-03-02 Biolife Science Qld Limited A vaccine composition and uses thereof
EP3297658A1 (de) 2015-05-18 2018-03-28 OncoQR ML GmbH Immunogene her2/neu-zusammensetzung
US11771749B2 (en) 2017-02-03 2023-10-03 The Medical College Of Wisconsin, Inc. KRAS peptide vaccine compositions and method of use
WO2019116089A2 (en) 2017-12-11 2019-06-20 Medizinische Universitaet Wien A method of producing a vaccine composition and uses thereof
WO2021002855A1 (en) * 2019-07-02 2021-01-07 Virago Vax Inc. Mammary tumor virus vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117165A (ja) * 1991-10-24 1993-05-14 Masakazu Ueda 抗癌剤
US7060284B1 (en) * 1999-08-03 2006-06-13 The Ohio State University Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
EP1236740B1 (de) * 2001-02-28 2012-07-18 Bio Life Science Forschungs- und Entwicklungsges.m.b.H. Vakzine gegen Krebserkrankungen, die mit dem HER-2/neu Onkogen assoziiert sind
CA2444854A1 (en) * 2001-04-26 2002-11-07 Avidia Research Institute Combinatorial libraries of monomer domains

Also Published As

Publication number Publication date
WO2007118660A3 (en) 2007-12-13
ATE473758T1 (de) 2010-07-15
AU2007237491B2 (en) 2012-11-01
IL194162A0 (en) 2011-08-01
EP1844788B1 (de) 2010-07-14
AU2007237491A1 (en) 2007-10-25
CA2649013C (en) 2017-05-02
IL194162A (en) 2014-04-30
US20090269364A1 (en) 2009-10-29
ES2348312T3 (es) 2010-12-02
EP2004218A2 (de) 2008-12-24
CA2649013A1 (en) 2007-10-25
EP1844788A1 (de) 2007-10-17
WO2007118660A2 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
DE602006015421D1 (de) HER-2/neu Multipeptidimpfstoff
PH12014501083A1 (en) Anticancer fusion protein
ECSP13012436A (es) ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS
WO2008046911A3 (en) Novel human micrornas associated with cancer
UY33826A (es) Proteínas de unión con dominios trivariables y sus usos
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
CY1116269T1 (el) Χρηση μιας πρωτεϊνης απο λουπινο
ATE387233T1 (de) Schutzhülse für nadeln mit absatz
BRPI0807896A2 (pt) Fórceps bipolares não-aderentes.
EA201000327A1 (ru) Белок
WO2010065954A3 (en) Sparc binding peptides and uses thereof
DOP2010000325A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
NZ604089A (en) Multivalent glycopeptide constructs and uses thereof
CR9512A (es) Metodos para el tratamiento de tumores de cerebro con anticuerpos
MX337436B (es) Proteina de funsion anticancer.
WO2008153933A3 (en) Soluble her2 and her3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of disease
AR080891A1 (es) Proteina de fusion robo 1-fc y su utilizacion en el tratamiento de tumores
BRPI0819092A2 (pt) Evolução direcionada usando proteínas que compreendem aminoácidos não naturais.
MX339203B (es) Proteina de fusion anticancer.
WO2008093058A3 (en) Peptides and their use
ATE527896T1 (de) Molkeproteinhydrolysat
ATE474917T1 (de) Verfahren zur erhöhung der in-vivo-gewinnung therapeutischer polypeptide
WO2014057436A3 (en) Anticancer conjugate
ES2530670T3 (es) Anticuerpo anti-FGF23 y composición farmacéutica que comprende el mismo
ATE538660T1 (de) Verfahren zur herstellung eines weizenproteinhydrolysats